Videos
Femtech in the Spotlight — An Interview with Wolfgang Hackl — Founder and CEO of OncoGenomX
July 11, 2022
Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.
Contacts
Related Resources
Related Blogs
Capabilities
Related Pages
Suggested News & Insights
Inside Strategic Partnerships: Clinical Trial Considerations and AI/Digital Health InsightsThursday, March 12, 2026Life Sciences College 2026Thursday, February 12, 2026OIG Releases Long-Awaited Medicare Advantage Compliance Program GuidanceFebruary 10, 2026Sidley Represents SanegeneBio in up to US$1.5 Billion Licensing Agreement With GenentechFebruary 10, 2026Sidley Represents Vivo Capital on Its Acquisition of Dutscher GroupFebruary 4, 2026Sidley Represents AdvanCell in Collaboration and Exclusive Licensing Agreement With 48Hour DiscoveryFebruary 3, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory